chr1-229431506-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PS2PM5PP2PP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The variant NM_001100.4:c.1127G>T in ACTA1 is a missense variant predicted to cause substitution of cysteine by phenylalanine at amino acid 376 (p.Cys376Phe) in exon 7/7. The variant is absent from gnomAD v4.1.1 with adequate coverage (PM2_Supporting). The REVEL computational prediction analysis tool gives a score of 0.955, which is above the threshold necessary to apply PP3. In addition, ACTA1, in which the variant was identified, is defined by the ClinGen Congenital Myopathies VCEP as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (PP2). This variant has been reported as a de novo observation with confirmed parental relationships in one proband with features associated with congenital myopathy which meets the criteria for PS2 (Invitae, SCV002228646.2). Another missense variant c.1127G>C (p.Cys376Ser) in the same codon is classified as pathogenic for autosomal dominant alpha-actinopathy (PM5, PMIDs:25890230, 19562689). In summary, the variant meets the criteria to be classified as likely pathogenic for autosomal dominant alpha-actinopathy. ACMG/AMP criteria met, as specified by the ClinGen Congenital Myopathies VCEP: PS2, PM5, PP2, PP3, PM2_Supporting (ClinGen Congenital Myopathies VCEP specifications version 2; 08/27/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA345144073/MONDO:0100084/147
Frequency
Consequence
NM_001100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTA1 | NM_001100.4 | c.1127G>T | p.Cys376Phe | missense_variant | 7/7 | ENST00000366684.7 | NP_001091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTA1 | ENST00000366684.7 | c.1127G>T | p.Cys376Phe | missense_variant | 7/7 | 1 | NM_001100.4 | ENSP00000355645.3 | ||
ACTA1 | ENST00000366683.4 | c.1049G>T | p.Cys350Phe | missense_variant | 7/7 | 5 | ENSP00000355644.4 | |||
ACTA1 | ENST00000684723.1 | c.992G>T | p.Cys331Phe | missense_variant | 6/6 | ENSP00000508084.1 | ||||
ENSG00000290037 | ENST00000702606.1 | n.141C>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Actin accumulation myopathy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 25, 2022 | For these reasons, this variant has been classified as Pathogenic. This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 376 of the ACTA1 protein (p.Cys376Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of ACTA1-related conditions (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 801630). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACTA1 protein function. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at